Recent Security Class Actions

Novo Nordisk A/S Common Stock (NYSE: NVO)

21 Days left to seek lead plaintiff status.

Company Name:Novo Nordisk A/S Common Stock
Stock Symbol:NYSE: NVO
Class Period Start:11/02/2022
Class Period End (inclusive):12/19/2024
Filing Deadline:03/25/2025

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements concerning Novo’s REDEFINE-1 Study. The Complaint further alleges that on December 20, 2024, Defendants disclosed information that was directly related to their prior misrepresentations and material omissions concerning Novo’s REDEFINE-1 Study and that this disclosure had the effect of correcting Defendants’ prior false and/or misleading statements which, in turn, caused Novo’s stock price to decline as investors reassessed the risks and benefits of investing in the Company.

Novo Nordisk A/S Common Stock (NYSE: NVO) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.